The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and ...
GLP-1 drugs Ozempic, Wegovy, Mounjaro and Zepbound can help patients lose anywhere from 15% to 20% of body weight. But what ...
Consumer health advertising is driving many employees to take action on GLP-1s. But without guidance, those decisions could ...
GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, ...
The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...
Obesity dipped in Minnesota as GLP‑1 use rose. Experts warn the long‑term picture and who pays are still unsettled.
Results showed that use of GLP-1 receptor agonists did not increase short-term medical or surgical complications among ...
Thinking about GLP-1 meds? A Hy-Vee dietitian explains how to eat to protect muscle, energy and digestion when your appetite ...
Popular GLP-1 receptor agonist drugs for weight loss, also known as GLP-1 RAs, appear to be similarly effective among ...
NC Poison Control says it received one or two calls a day, on average, in 2025 for GLP-1 drugs, with 80% of cases involving a ...
Research led by Penn Dental's Henry Daniell investigates the use of a lettuce-based, plant-encapsulated delivery platform as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results